表面活性剂辅助治疗急性淋巴细胞白血病婴儿的卡氏肺孢子虫肺炎。
Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia.
作者信息
Slater A J, Nichani S H, Macrae D, Wilkinson K A, Novelli V, Tasker R C
机构信息
Paediatric Intensive Care Unit, Hospitals for Sick Children, London, UK.
出版信息
Intensive Care Med. 1995 Mar;21(3):261-3. doi: 10.1007/BF01701485.
Abstract
We report successful treatment of adult respiratory distress syndrome (ARDS) with artificial surfactant (40mg/kg, Colfosceril Palmitate, ‘Exosurf’, Wellcome) in an infant with severe pneumonitis.
摘要
我们报告了在一名患有严重肺炎的婴儿中，使用人工表面活性剂（40mg/kg，棕榈酰可尔氟，“Exosurf”，威康公司）成功治疗成人呼吸窘迫综合征（ARDS）的案例。
相似文献
1
Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia.表面活性剂辅助治疗急性淋巴细胞白血病婴儿的卡氏肺孢子虫肺炎。
Intensive Care Med. 1995 Mar;21(3):261-3. doi: 10.1007/BF01701485.
2
Colfosceril in an infant with adult respiratory distress syndrome.用考福斯酯治疗一名患有成人呼吸窘迫综合征的婴儿。
Clin Pharm. 1992 Oct;11(10):880-2.
3
[The effects of administering surfactant to two adolescents with leukemia suffering from respiratory distress].[给两名患有呼吸窘迫的白血病青少年使用表面活性剂的效果]
Cah Anesthesiol. 1991;39(4):227-32.
4
Exogenous surfactant therapy for ARDS.急性呼吸窘迫综合征的外源性表面活性剂治疗
Expert Opin Investig Drugs. 2006 Jan;15(1):47-58. doi: 10.1517/13543784.15.1.47.
5
Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.
Pediatr Pulmonol. 1997 Nov;24(5):370-3. doi: 10.1002/(sici)1099-0496(199711)24:5<370::aid-ppul10>3.0.co;2-6.
6
An outbreak of Pneumocystis carinii pneumonia in children with malignancy.恶性肿瘤患儿中卡氏肺孢子虫肺炎的暴发。
J Paediatr Child Health. 1994 Apr;30(2):173-5. doi: 10.1111/j.1440-1754.1994.tb00605.x.
7
Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia.天然表面活性剂在一名患有卡氏肺孢子虫肺炎的HIV感染婴儿中的应用。
Intensive Care Med. 1996 Jun;22(6):611-2. doi: 10.1007/BF01708109.
8
Lucinactant: in neonatal respiratory distress syndrome.卢西纳克坦：用于新生儿呼吸窘迫综合征。
Treat Respir Med. 2005;4(2):139-45; discussion 146-7. doi: 10.2165/00151829-200504020-00008.
9
Detection of pneumocystis DNA in nasopharyngeal aspirates of leukaemic infants with pneumonia.白血病合并肺炎婴幼儿鼻咽抽吸物中肺孢子虫DNA的检测
Arch Dis Child. 1994 Sep;71(3):254-5. doi: 10.1136/adc.71.3.254.
10
Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.
Intensive Care Med. 1991;17(8):475-8. doi: 10.1007/BF01690770.
引用本文的文献
1
[An infant with leukemia complicated by pneumonia: A case report and literature review].[一名白血病合并肺炎的婴儿：病例报告及文献综述]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Jun 28;50(6):1106-1112. doi: 10.11817/j.issn.1672-7347.2025.240433.
2
Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management.血液系统恶性肿瘤患儿的肺炎：诊断与管理方法
J Fungi (Basel). 2020 Dec 2;6(4):331. doi: 10.3390/jof6040331.
3
[Intraoperative Aspiration].[术中误吸]
Zhongguo Fei Ai Za Zhi. 2020 May 20;23(5):393-401. doi: 10.3779/j.issn.1009-3419.2020.101.22.
4
Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma.多发性骨髓瘤患者血清样本的代谢特征分析
Front Pharmacol. 2018 Aug 22;9:884. doi: 10.3389/fphar.2018.00884. eCollection 2018.
5
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.HIV暴露儿童和HIV感染儿童机会性感染的预防和治疗指南：美国国立卫生研究院、疾病控制与预防中心、美国传染病学会HIV医学协会、儿科传染病学会及美国儿科学会的建议
Pediatr Infect Dis J. 2013 Nov;32 Suppl 2(0 2):i-KK4. doi: 10.1097/01.inf.0000437856.09540.11.
7
Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia.天然表面活性剂在一名患有卡氏肺孢子虫肺炎的HIV感染婴儿中的应用。
Intensive Care Med. 1996 Jun;22(6):611-2. doi: 10.1007/BF01708109.
本文引用的文献
1
Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.实验性卡氏肺孢子虫肺炎中的表面活性物质磷脂和灌洗磷脂酶A2
Am Rev Respir Dis. 1986 Sep;134(3):526-31. doi: 10.1164/arrd.1986.134.3.526.
2
High-dose corticosteroids in patients with the adult respiratory distress syndrome.成人呼吸窘迫综合征患者使用大剂量皮质类固醇激素。
N Engl J Med. 1987 Dec 17;317(25):1565-70. doi: 10.1056/NEJM198712173172504.
3
An expanded definition of the adult respiratory distress syndrome.成人呼吸窘迫综合征的扩展定义。
Am Rev Respir Dis. 1988 Sep;138(3):720-3. doi: 10.1164/ajrccm/138.3.720.
4
Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS.卡氏肺孢子虫肺炎合并艾滋病患者支气管肺泡灌洗中性粒细胞增多的预后意义
Am Rev Respir Dis. 1989 Jun;139(6):1336-42. doi: 10.1164/ajrccm/139.6.1336.
5
Surfactant therapy.表面活性剂疗法
Resuscitation. 1989;18 Suppl:S37-49. doi: 10.1016/0300-9572(89)90052-x.
6
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎早期使用皮质类固醇辅助治疗的对照试验。加利福尼亚协作治疗组。
N Engl J Med. 1990 Nov 22;323(21):1451-7. doi: 10.1056/NEJM199011223232104.
7
Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro.
Am J Respir Cell Mol Biol. 1991 Jan;4(1):33-41. doi: 10.1165/ajrcmb/4.1.33.
8
Alveolar-arterial oxygen gradient as a predictor of outcome in patients with nonneonatal pediatric respiratory failure.肺泡-动脉血氧梯度作为非新生儿小儿呼吸衰竭患者预后的预测指标。
J Pediatr. 1991 Dec;119(6):935-8. doi: 10.1016/s0022-3476(05)83048-3.
9
Surfactant inactivation and surfactant replacement in experimental models of ARDS.急性呼吸窘迫综合征实验模型中的表面活性剂失活与表面活性剂替代
Acta Anaesthesiol Scand Suppl. 1991;95:22-8. doi: 10.1111/j.1399-6576.1991.tb03396.x.
10
Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.
Intensive Care Med. 1991;17(8):475-8. doi: 10.1007/BF01690770.
Zotero 插件